Between 1 January 2021 and 1 July 2021, 120 blood samples from acute myocardial infarction (AMI) patients—60 as controls and 60 patients—of both sexes who were accepted to the cardiac surgery unit at AL- Salam teaching hospital, the intensive cardiac care unit, and outpatient clinics in Mosul City/Iraq, were taken. In the presented research, the ejection fraction regarding patients with AMI was evaluated by echocardiography, and the blood-liver enzyme levels (ALP and AST \ ALT ratio) were examined in those patients. The findings indicate that patients with AMI in the age range of 35 to 45 years have a (52.41) % ejection fraction (EF) rate, which is closer to (51.344%) than it is in samples from healthy controls. In addition to that, findings indicate that patients in an age range of 46 to 56 years have heart failure with a mid-range EF (HFmrEF), with a (48.13%) percentage, whereas this heart failure type in healthy controls has been preserved ejection fraction (HFpEF) with (53.368 %). In the case of the comparison of the AST/ALT ratio and EF across all of the age groups that have been tested, the results suggest a significant level (P ≤ 0.050) relation between the ALP enzyme and EF for the patients within the (35-45 years) age group additionally, as there has been a positive and weak linear connection (r = 0.10650) and a nominal p-value (p = 0.47240) at a threshold of probability ≤ P 0.050, the link and correlation between the AST/ALT ratio and cardiac EF have been investigated. Keywords: ALP enzyme, AMI patients, Ejection Fraction, AST \ ALT ratio.
Background: The dysfunction in the genes that regulate cortisol production may lead to an increase or overproduction of the hormone and thus affect the functioning of the heart, which may lead to Myocardial infarction. Aim: The aim of our study was to find a correlation between increasing the DNA copy numbers that encode cortisol biosynthesis enzymes and Myocardial infarction disease. Methods: Between the first of January 2021 and the first of July 2021, 120 blood samples from the patients with the acute myocardial infarction (AMI)—60 samples as controls and 60 patients—of both sexes who were admitted to the Unit of the Cardiac Surgery at AL- Salam General Teaching Hospital, the Intensive Cardiac Care Unit, and outpatient health centers in Mousul, Nineveh province/Iraq, were taken. The CYP11A, CYP17A, and CYP11B1 genes implicated in cortisol biosynthesis were found in this work using qRT-PCR. Results: The results of this investigation showed a considerable difference between the age groups of AMI patients and healthy control group in means of amplicon copy counts of CYP11A, CYP17A, and CYP11B1 coding genes. The gene coding for the cytochrome CYP17A enzyme was shown to have a significantly higher number of amplicons in all age groups of the patients, but particularly in the second group (46–56 years) in comparison to healthy control group Conclusion: The results of this study demonstrated for the first time that there were significant correlation between three steroid hormone biosynthesis genes and Acute Myocardial Infarction (AMI) disease by utilizing RT-PCR Technique which revealed a significant increase in the amplicon copy numbers of CYP17 ,CYP11A ,CYP11B genes in all patient's age groups compared with healthy control group. Keywords: AMI patients, Cortisol biosynthesis, CYP17A , CYP11A and CYP11B1 genes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.